Compass Therapeutics Inc (CMPX)
1.60
+0.06
(+3.90%)
USD |
NASDAQ |
May 16, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Price to Book Value: 1.402 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 1.349 |
| May 14, 2024 | 1.415 |
| May 13, 2024 | 1.367 |
| May 10, 2024 | 1.402 |
| May 09, 2024 | 1.393 |
| May 08, 2024 | 1.384 |
| May 07, 2024 | 1.472 |
| May 06, 2024 | 1.489 |
| May 03, 2024 | 1.489 |
| May 02, 2024 | 1.445 |
| May 01, 2024 | 1.375 |
| April 30, 2024 | 1.262 |
| April 29, 2024 | 1.279 |
| April 26, 2024 | 1.270 |
| April 25, 2024 | 1.296 |
| April 24, 2024 | 1.296 |
| April 23, 2024 | 1.332 |
| April 22, 2024 | 1.305 |
| April 19, 2024 | 1.288 |
| April 18, 2024 | 1.305 |
| April 17, 2024 | 1.340 |
| April 16, 2024 | 1.375 |
| April 15, 2024 | 1.384 |
| April 12, 2024 | 1.419 |
| April 11, 2024 | 1.402 |
| Date | Value |
|---|---|
| April 10, 2024 | 1.402 |
| April 09, 2024 | 1.463 |
| April 08, 2024 | 1.489 |
| April 05, 2024 | 1.489 |
| April 04, 2024 | 1.524 |
| April 03, 2024 | 1.621 |
| April 02, 2024 | 1.577 |
| April 01, 2024 | 1.612 |
| March 28, 2024 | 1.834 |
| March 27, 2024 | 1.899 |
| March 26, 2024 | 1.834 |
| March 25, 2024 | 1.899 |
| March 22, 2024 | 1.973 |
| March 21, 2024 | 2.075 |
| March 20, 2024 | 1.964 |
| March 19, 2024 | 1.982 |
| March 18, 2024 | 2.084 |
| March 15, 2024 | 2.121 |
| March 14, 2024 | 1.667 |
| March 13, 2024 | 1.882 |
| March 12, 2024 | 1.779 |
| March 11, 2024 | 1.719 |
| March 08, 2024 | 1.685 |
| March 07, 2024 | 1.650 |
| March 06, 2024 | 1.685 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.904
Minimum
Mar 28 2022
15.88
Maximum
Nov 18 2021
4.108
Average
2.230
Median
May 25 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 5.952 |
| AIM ImmunoTech Inc | 2.091 |
| IGC Pharma Inc | 4.208 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.868 |
Price to Book Value Related Metrics
| Price | 1.60 |
| Earnings Yield | -21.88% |
| Market Cap | 220.14M |